Combined eff ect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Steffen Leth, Mariane H Schleimann, Sara K Nissen, Jesper F Hojen, Rikke Olesen, Mette E Graversen, Sofi E Jorgensen, Anne Sofie kjaer, Paul W Denton, Alejandra Mork, Maja A Sommerfelt, Kim Krogsgaard, Lars Ostergaard, Thomas A Rasmussen, Martin Tolstrup, Ole Schmeltz Sogaard